Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=29996827
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29996827
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 BMC+Biol
2018 ; 16
(1
): 75
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting
the HIV reservoir
#MMPMID29996827
Roychoudhury P
; De Silva Feelixge H
; Reeves D
; Mayer BT
; Stone D
; Schiffer JT
; Jerome KR
BMC Biol
2018[Jul]; 16
(1
): 75
PMID29996827
show ga
BACKGROUND: RNA-guided CRISPR/Cas9 systems can be designed to mutate or excise
the integrated HIV genome from latently infected cells and have therefore been
proposed as a curative approach for HIV. However, most studies to date have
focused on molecular clones with ideal target site recognition and do not account
for target site variability observed within and between patients. For clinical
success and broad applicability, guide RNA (gRNA) selection must account for
circulating strain diversity and incorporate the within-host diversity of HIV.
RESULTS: We identified a set of gRNAs targeting HIV LTR, gag, and pol using
publicly available sequences for these genes and ranked gRNAs according to global
conservation across HIV-1 group M and within subtypes A-C. By considering paired
and triplet combinations of gRNAs, we found triplet sets of target sites such
that at least one of the gRNAs in the set was present in over 98% of all globally
available sequences. We then selected 59 gRNAs from our list of highly conserved
LTR target sites and evaluated in vitro activity using a loss-of-function LTR-GFP
fusion reporter. We achieved efficient GFP knockdown with multiple gRNAs and
found clustering of highly active gRNA target sites near the middle of the LTR.
Using published deep-sequence data from HIV-infected patients, we found that
globally conserved sites also had greater within-host target conservation.
Lastly, we developed a mathematical model based on varying distributions of
within-host HIV sequence diversity and enzyme efficacy. We used the model to
estimate the number of doses required to deplete the latent reservoir and achieve
functional cure thresholds. Our modeling results highlight the importance of
within-host target site conservation. While increased doses may overcome low
target cleavage efficiency, inadequate targeting of rare strains is predicted to
lead to rebound upon cART cessation even with many doses. CONCLUSIONS: Target
site selection must account for global and within host viral genetic diversity.
Globally conserved target sites are good starting points for design, but
multiplexing is essential for depleting quasispecies and preventing viral load
rebound upon therapy cessation.